(Q46029869)

English

Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia.

scientific article published on 2 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

0 references

author name string

M R Kuzman

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

V Medved

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

N Bozina

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

J Grubišin

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

N Jovanovic

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

J Sertic

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

publication date

2 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

The Pharmacogenomics Journal

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

11

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

35-44

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Genetics of antipsychotic treatment emergent weight gain in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Involvement of 5-HT2Receptor in Imipramine-Induced Hyperglycemia in Mice

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

-759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Role of P-glycoprotein in pharmacokinetics: clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

In vitro P-glycoprotein affinity for atypical and conventional antipsychotics

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Metabolic syndrome in female patients with schizophrenia treated with second generation antipsychotics: a 3-month follow-up

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Performing the exact test of Hardy-Weinberg proportion for multiple alleles

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Pedigree disequilibrium tests for multilocus haplotypes.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

No gene is an island: the flip-flop phenomenon

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Complex HTR2C linkage disequilibrium and promoter associations with body mass index and serum leptin.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

The effects of antipsychotic drugs on the mRNA levels of serotonin 5HT2A and 5HT2C receptors

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Pancreatitis associated with atypical antipsychotics: from the Food and Drug Administration's MedWatch surveillance system and published reports

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.7

21 January 2018

Identifiers

10.1038/TPJ.2010.7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/20195292

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46029869&oldid=2207544635"